Heading to ISPOR 2023, a deepdive in health economics and outcomes research (HEOR) with worldwide experts

• Billy Amzal – CEO: Billy, our expert in healthcare outcomes simulation, will explain how we’re shaping the healthcare industry.
• Frank Ahrens – CCO: Frank is at the forefront of healthcare innovation, driving meaningful change.
• Mathilde Berthelot – Head of Operations: Mathilde brings a wealth of knowledge in predictive medicine and real-world data analysis.
• Mélissa Rollot – Data Science Project Manager: Mélissa will be on hand to share insights about our use cases and scientific publications.

Find us at Booth #33 in Hall C2, where we invite you to explore the future of healthcare. Discover the latest in healthcare analytics, real-world data utilization, and data-driven decision-making. Collectively, we’re advancing healthcare, molding a more responsible, efficient, and sustainable industry. Our journey towards this vision is grounded in crafting foundational models powered by Real-World Data. These models empower us to simulate the diverse aspects of health conditions, their progression, and management, while extending the reach of clinical trial results to a broader patient population.

Posters

We present 5 posters about our expertise and experience in 2 different consortiums.

 Poster 1: AIOLOS Consortium – Artificial Intelligence (AI) Tools for Outbreak Detection and Response: A Transnational Platform for Surveillance, Monitoring and Decision Support.

• Poster Session 1 – 13 November 2023
• Look at the abstract on ISPOR Website

 Poster 2: MORE Europa Consortium – Criteria and methods applied to decision-making to embark on late-stage clinical trials with a multi-stakeholder perspective.

• Poster Session 3 – 14 November 2023
• Look at the abstract on ISPOR Website

 Poster 3: MORE Europa Consortium – Existing automated tools to assist evidence generation and better qualification of registries and real-world data. A systematic review from the More-EUROPA project.

• Poster Session 2 – 13 November 2023
• Look at the abstract on ISPOR Website

 Poster 4: MORE Europa Consortium – Existing Practices for the Identification, Selection, or Assessment of Registries and Real-Word Data for Regulatory/HTA Purposes: A More-EUROPA Project Systematic Review

• Poster Session 1 – 13 November 2023
• Look at the abstract on ISPOR Website

  Poster 5: MORE Europa Consortium – What are unmet needs in the use of registries in regulatory/HTA decision-making in Europe?: A survey-based approach from the More-EUROPA project.

• Poster Session 3 – 14 November 2023
• Look at the abstract on ISPOR Website

New Press Release : Quinten Health and C-Path Partner to Deliver Regulatory-grade Patient Simulators

This new partnership aims to jointly design and advance a groundbreaking approach enabling regulatory-grade disease and care simulation for reducing risks in value-based trial designs and real-world prospective studies. By combining Quinten Health’s predictive disease and care modeling technologies, which enable clinical trial and post-authorization study design optimization, with C-Path’s expertise in Model-Informed Drug Development (MIDD), drug development and lifecycle can be de-risked and accelerated by reducing the incertainty due to disease & care heterogeneity, progression and outcomes in real-life settings.

You’re going to [name of the event] [year]?

 

You’re not register yet ?

• Visit the ISPOR Europe website
• Discover the exhibition program
• Discover the posters